Driven, athletic, and a role model to his community, 20-year-old Eddie Kaufman has been fighting an aggressive form of blood ...

When Cells at Work! hit theaters in Japan, nobody expected it to become one of the year’s biggest cultural surprises.

Oesophageal adenocarcinoma has an extremely poor prognosis, and improving outcomes via therapy remains particularly challenging in such a heterogeneous cancer. Another avenue for improving outcomes ...

ABOUT 5.7 MILLION men could have an autoimmune disease, according to a 2024 study published in the Journal of Clinical Investigation. The authors believe it’s the first to estimate the prevalence of ...

“The eyes are the window to the soul—and they’re also the window to the body,” says Douglas Wisner, MD, an ophthalmologist ...

AbbVie said on Monday its treatment for a group of blood cancers failed to meet the main goal of significantly improving the ...

Roche and AbbVie have once again come up short in their attempt to gain an additional indication for their blockbuster blood ...

“These results demonstrate that it is possible to detect circulating tumor DNA more than three years prior to clinical ...

Although cancer of the appendix is rare — typically, it's estimated to affect about 1 or 2 people for every 1 million in the ...

The AbbVie-Roche cancer drug venetoclax failed to meet its primary endpoint in a phase 3 trial to treat newly diagnosed ...

To help boost donations, MBS is offering a $50 Visa gift card to all platelet donors as a thank-you for their lifesaving ...

A new hereditary condition has been discovered that affects patients' ability to repair DNA – leaving them both at greater ...